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2007 is now history; it was an excellent year for the Journal of Thoracic Oncology(JTO). I want to start by thanking the many reviewers who have volunteered their
time and effort to help improve the quality of the published manuscripts. Following this
editorial is a list of those who participated in JTO manuscript reviews in 2006 and 2007.
On average, each person on the list has participated in two reviews, but many of these
individuals have done 10 or more. On behalf of the associate editors and editorial staff, we
sincerely THANK YOU!!
Total manuscript submissions have experienced a huge increase, from 250 in 2006
to nearly 450 in 2007. Along with the increased numbers, there has been continued
improvement in the quality of submissions, allowing the associate editors to be more
selective in what we deliver to our membership and readers. Overall, the time from
manuscript submission to first decision is 23.5 days (32 days for original articles only).
The majority of JTO reviewers are completing their review within the requested 2 weeks
and approximately 85% are completed within 3 weeks. The challenge is still with that final
15% of late reviews. We will work hard to decrease the late reviews as we know that
timely decisions are a priority for our authors.
The geographic locations from which manuscripts were submitted in 2007 were as
follows: Europe (Eastern and Western) (33%), Asia/Australia (29%), North American
(33%), and the rest of the world (4%). Especially encouraging was the fact that we
received manuscripts from a number of countries for the first time.
The International Association for the Study of Lung Cancer (IASLC) Staging
Committee published six landmark papers in JTO in 2007, including the proposed new
international staging system for non-small cell lung cancer.1–6 The new IASLC Staging
System is working its way through the International Union Against Cancer and the
American Joint Committee on Cancer approval processes and it is anticipated that it will
be adopted officially (with minimal change) in January 2009.5
Other highlights of the year include the publication and distribution in Spain of three
Spanish language issues of JTO. These were selected from the English language version
under the direction of Dr. Ramon Rami-Porta, Editor of the Spanish edition. Our thanks
to Dr. Rami-Porta for his dedication and making the Spanish edition of JTO a reality. In
2008, an additional 2800 Spanish language JTO copies will be distributed to physicians
and scientists in Mexico and South America. We hope that this dissemination of
information will increase membership and participation in IASLC by physicians and
scientists from those countries.
In December 2007, the first issue of a Japanese language version of JTO was
published. The editors of the Japanese language JTO are Drs. Nagahiro Saijo, Harubumi
Kato, and Ryosuke Tsuchiya. It is anticipated that there will be four Japanese language
issues per year. Each issue contains two full article and four abstract article translations
selected by the editors from the English language version. Congratulations to our Japanese
editors for their efforts in bringing this project to fruition.
The first 2 years for our new journal have gone exceptionally well. There have been
many successes (and only a few glitches)—the reasons are myriad. First, has been the
tremendous support by you, the members of IASLC. Our publisher, Lippincott-Williams-
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and-Wilkins and David Myers, in particular, have been out-
standing in delivering everything agreed to and more. The
JTO managing editor, Mary Sharkey, has been superb. She is
amazing at keeping the process of publication on track and at
fixing any problem that arises. The associate editors, a veri-
table list of Who’s Who in Lung Cancer, have given a
tremendous amount of time and effort to making the JTO a
first rate journal. My sincere thanks to each of you for these
efforts.
Our plans for 2008 are to continue to improve. We
anticipate a further rise in the number of manuscript
submissions and we will strive to shorten the time to first
decision. We hope to eliminate the number of reviews that
take more than 2 months. We are planning to increase the
number of “State-of-the-Art: Concise Review” articles.
We will continue our efforts in “Pathway of the Month”
articles to help keep us informed on the rapidly changing
basic science areas. Finally, under the leadership of Dr.
John Crowley, the statistical editor of JTO, we are plan-
ning to launch a series of articles on statistics and clinical
trial design. These will be delivered in useful portions,
much like the pathway articles.
Remember, this is your JTO. If you have ideas that you
think would enhance the journal, please share your ideas with
us. If there are things that you think we are doing wrong, or
could do better, please let us know. As an editor, I am open
to new ideas and would welcome your comments and sug-
gestions. Our goal is to deliver to you, the membership, the
highest quality journal possible.
REFERENCES
1. Rami-Porta R, Ball D, Crowley J, et al. The IASLC Lung Cancer
Staging Project: proposals for the revision of the T descriptors in the
forthcoming (seventh) edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:593–602.
2. Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer
Staging Project: proposals for the revision of the N descriptors in the
forthcoming seventh edition of the TNM classification for lung cancer.
J Thorac Oncol 2007;2:603–612.
3. Postmus PE, Brambilla E, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for the Revision of the M descriptors in the
forthcoming (seventh) edition of the TNM classification of lung cancer.
J Thorac Oncol 2007;2:686–693.
4. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer
Staging Project: validation of the proposals for revision of the T, N, and
M descriptors and consequent stage groupings in the forthcoming
(seventh) edition of the TNM classification of malignant tumours.
J Thorac Oncol 2007;2:694–705.
5. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer
Staging Project: proposals for the revision of the TNM stage groupings
in the forthcoming (seventh) edition of the TNM classification of
malignant tumours. J Thorac Oncol 2007;2:706–714.
6. Shepherd FA, Crowley J, Van Houtte P, et al. The International Asso-
ciation for the Study of Lung Cancer Lung Cancer Staging Project:
proposals regarding the clinical staging of small cell lung cancer in the
forthcoming (seventh) edition of the tumor, node, metastasis classifica-
tion for lung cancer. J Thorac Oncol 2007;2:1067–1077.
Jett Journal of Thoracic Oncology • Volume 3, Number 3, March 2008
Copyright © 2008 by the International Association for the Study of Lung Cancer204
